195 related articles for article (PubMed ID: 14529041)
1. Toward evidence-based prescribing at end of life: a comparative review of temazepam and zolpidem for the treatment of insomnia.
Bain KT; Weschules DJ; Knowlton CH; Gallagher R
Am J Hosp Palliat Care; 2003; 20(5):382-8. PubMed ID: 14529041
[TBL] [Abstract][Full Text] [Related]
2. Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?
Weschules DJ; Maxwell T; Reifsnyder J; Knowlton CH
Am J Hosp Palliat Care; 2006; 23(2):135-49. PubMed ID: 16572752
[TBL] [Abstract][Full Text] [Related]
3. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
Voshaar RC; van Balkom AJ; Zitman FG
Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
[TBL] [Abstract][Full Text] [Related]
4. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.
Partinen M; Hirvonen K; Hublin C; Halavaara M; Hiltunen H
Sleep Med; 2003 Nov; 4(6):553-61. PubMed ID: 14607350
[TBL] [Abstract][Full Text] [Related]
5. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
Lähteenmäki R; Neuvonen PJ; Puustinen J; Vahlberg T; Partinen M; Räihä I; Kivelä SL
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):330-340. PubMed ID: 30295409
[TBL] [Abstract][Full Text] [Related]
7. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
8. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
9. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
Rosenberg RP
Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
Arbon EL; Knurowska M; Dijk DJ
J Psychopharmacol; 2015 Jul; 29(7):764-76. PubMed ID: 25922426
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center.
Gray E; Bradley B
J Am Pharm Assoc (2003); 2019; 59(4S):S146-S150. PubMed ID: 31248847
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.
Nowell PD; Mazumdar S; Buysse DJ; Dew MA; Reynolds CF; Kupfer DJ
JAMA; 1997 Dec 24-31; 278(24):2170-7. PubMed ID: 9417012
[TBL] [Abstract][Full Text] [Related]
13. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Puustinen J; Lähteenmäki R; Polo-Kantola P; Salo P; Vahlberg T; Lyles A; Neuvonen PJ; Partinen M; Räihä I; Kivelä SL
Eur J Clin Pharmacol; 2014 Mar; 70(3):319-29. PubMed ID: 24337417
[TBL] [Abstract][Full Text] [Related]
14. Pilot evaluation of hypnotic medication during acute traumatic stress response.
Mellman TA; Byers PM; Augenstein JS
J Trauma Stress; 1998 Jul; 11(3):563-9. PubMed ID: 9690193
[TBL] [Abstract][Full Text] [Related]
15. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
16. Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia.
Erman MK; Loewy DB; Scharf MB
Curr Med Res Opin; 2005 Feb; 21(2):223-30. PubMed ID: 15801993
[TBL] [Abstract][Full Text] [Related]
17. Treatment of insomnia in hospitalized patients.
Lenhart SE; Buysse DJ
Ann Pharmacother; 2001 Nov; 35(11):1449-57. PubMed ID: 11724098
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
19. 'Hypnotic' prescription patterns in a large managed-care population.
Roehrs T; Roth T
Sleep Med; 2004 Sep; 5(5):463-6. PubMed ID: 15341891
[TBL] [Abstract][Full Text] [Related]
20. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study.
Joester J; Vogler CM; Chang K; Hilmer SN
Drugs Aging; 2010 Nov; 27(11):915-24. PubMed ID: 20964465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
